We are live on ! Find out more
BCM

Burrage Capital Management Portfolio holdings

AUM $99.7M
1-Year Est. Return 66.05%
This Fund
S&P 500
This Quarter Est. Return
+11.93%
1 Year Est. Return
+66.05%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$123M
AUM Growth
-$7.8M
Cap. Flow
-$9.25M
Cap. Flow %
-7.49%
Top 10 Hldgs %
57.11%
Holding
32
New
7
Increased
5
Reduced
13
Closed
5

Top Buys

Rank Stock Value
1
EPIX
ESSA Pharma
EPIX
+$5.52M
2
HRMY icon
Harmony Biosciences
HRMY
+$5.26M
3
TCDA
Tricida, Inc. Common Stock
TCDA
+$4.14M
4
TVRD
Tvardi Therapeutics
TVRD
+$3.42M
5
GERN icon
Geron
GERN
+$3.42M

Top Sells

Rank Stock Value
1
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$9.59M
2
INSM icon
Insmed
INSM
+$5.14M
3
AUPH icon
Aurinia Pharmaceuticals
AUPH
+$4.65M
4
KRRO icon
Korro Bio
KRRO
+$4.39M
5
EPZM
Epizyme, Inc
EPZM
+$3.79M

Sector Composition

Rank Sector Weight
1 Healthcare 99.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TPTX
26
PUT
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$861K 0.7%
+700
New +$83.2K
NTLA icon
27
PUT
Intellia Therapeutics
NTLA
$1.57B
$46K 0.04%
+630
New +$42.3K
AUPH icon
28
Aurinia Pharmaceuticals
AUPH
$2.07B
– –
-336,384
Closed -$4.65M
AUTL
29
Autolus Therapeutics
AUTL
$532M
– –
-15,006
Closed -$134K
INSM icon
30
Insmed
INSM
$28.7B
– –
-154,562
Closed -$5.14M
KRRO icon
31
Korro Bio
KRRO
$175M
– –
-2,493
Closed -$4.39M
ISEE
32
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
– –
-1,388,136
Closed -$9.59M
1
2

Similar funds

WCM
Weld Capital Management New York $98.8M AUM 52.83% 1-Year Est. Return
CCM
Coe Capital Management Highland Park, Illinois $106M AUM 53.24% 1-Year Est. Return
RGM
ROAM Global Management New York $117M AUM
TCM
Taal Capital Management Boston, Massachusetts $122M AUM 50.45% 1-Year Est. Return
RC
Regents Capital Hong Kong $76.8M AUM
AC
Aperimus Capital Marina Del Rey, California $62.2M AUM 47.35% 1-Year Est. Return
QVT
Quantitative Value Technologies Overland Park, Kansas $60.7M AUM
WFWM
Wechter Feldman Wealth Management Parsippany, New Jersey $143M AUM 25.17% 1-Year Est. Return

Burrage Capital Management's Q1 2021 Portfolio in Review

As of Q1 2021, Burrage Capital Management held 32 positions worth $123M, down 5.9% from $131M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Burrage Capital Management withdrew a net $9.25M in Q1 2021, closing 5 positions and reducing 13 holdings. Its most notable exit was IVERIC bio, Inc. Common Stock, an estimated $9.59M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, down from 100% a quarter earlier.

Against the trend, Burrage Capital Management opened a new position in ESSA Pharma worth $6.9M.

  • Burrage Capital Management's largest Q1 2021 buy was ESSA Pharma: 237,442 shares worth $6.9M.
  • Burrage Capital Management added most to Black Diamond Therapeutics in Q1 2021, an estimated $2.04M increase.
  • Burrage Capital Management's biggest Q1 2021 reduction was Epizyme, Inc, cutting an estimated $3.79M.
  • Burrage Capital Management fully exited IVERIC bio, Inc. Common Stock in Q1 2021, selling an estimated $9.59M.
  • Burrage Capital Management's ten largest holdings make up 57% of its $123M portfolio in Q1 2021.
  • Burrage Capital Management opened 7 new positions and closed 5 in Q1 2021.
  • Burrage Capital Management's portfolio value fell 5.9% quarter-over-quarter to $123M.

Based on Burrage Capital Management's 13F filing for Q1 2021, filed 17 May 2021.